PTEN and glioblastoma: Several molecular markers, such as isocitrate dehydrogenase, O6-methylguanine DNA methyltransferase, phosphatase and tensin homolog, and epidermal growth factor receptor, are conventionally examined in clinical GBM cases20,21.